Another Cannabis Opportunity Awaits the Patient Investor

Investors that have an appreciation for the long-term growth prospects that the cannabis sector can provide should consider the opportunity from investing in Hexo Corp. (TSX:HEXO)(NYSE:HEXO).

| More on:
edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Cannabis stocks paved the way to some massive investor gains over the past two years, and that growth-inspired focus was a key reason for investing in the sector.

Unfortunately, much of that growth has stalled in recent months, with some prominent cannabis stocks now trading at levels not seen since the turn of the year. One such investment is Hexo (TSX:HEXO)(NYSE:HEXO), which, despite trading near its 52-week low, remains a stellar investment option to consider.

Why Hexo is a great investment in disguise

On paper, Hexo has all the makings of a great long-term investment. Hexo has established itself as a leading supplier to several provinces and diversified into other areas such as its award-winning line of elixir sprays. The company has also partnered with Molson Coors Canada to produce a cannabis-infused beverage from the Truss Beverages startup.

Turning to the supply side of the business, Hexo’s still recent acquisition of Newstrike brands established Hexo as one of the key players in the market. The deal also muted some of the concerns of critics that viewed Hexo as more of a takeover target for its larger peers rather than a competitor on an equal footing.

The Newstrike deal also provided Hexo with a cultivation capacity boost to a whopping 150,000 kilograms. Keep in mind that in the most recent quarter (pre-acquisition) Hexo generated just shy of 10,000 kilograms of dried cannabis.

Turning to results, in the most recent quarter, Hexo reported a whopping 1,250% year-over-year increase in net revenue to $13,01 million. Unfortunately, most investors focused on the small, but noted decline in revenue over the previous quarter, where net revenues came in at $13.43 million.

While the decrease warrants a closer look, investors should be mindful that this is still a very new and still volatile segment of the market, with production still ramping up. If anything, the next two quarters should prove telling for investors, as the impact of Hexo’s new production facilities and synergies from the Newstrike deal will provide a boost to earnings.

The next phase of legalization, which includes edibles, is likely to provide yet another boost to Hexo’s well-diversified business into next year.

What should you do?

Given the talking points above, there’s little reason to doubt the long-term potential of Hexo. The company is well positioned to thrive in the coming quarters, particularly as products come to maturation through its significantly larger production facilities. By way of example, the first harvest from that 1,000,000-square-foot flagship facility was announced earlier this summer.

Additionally, keep in mind that in the most recent quarter, Hexo stated that the company was on track to hit $400 million in net revenue during fiscal 2020 and double net revenue in fiscal 2019.

In my opinion, Hexo remains a stellar long-term growth opportunity. While the stock is not without risk and could drop a little further before bottoming, at the current price point, investors are buying Hexo at a discounted rate not seen since the turn of the year.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Demetris Afxentiou owns shares of HEXO. The Motley Fool owns shares of Molson Coors Brewing.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »